Your browser doesn't support javascript.
loading
Single-molecule 3D imaging of HIV cellular entry by liquid-phase electron tomography.
Kong, Lingli; Liu, Jianfang; Zhang, Meng; Lu, Zhuoyang; Ren, Amy; Liu, Jiankang; Li, Jinping; Ren, Gang Gary.
Afiliación
  • Kong L; Lawrence Berkeley National Laboratory.
  • Liu J; Lawrence Berkeley National Laboratory.
  • Zhang M; Lawrence Berkeley National Laboratory.
  • Lu Z; Lawrence Berkeley National Laboratory.
  • Ren A; Lawrence Berkeley National Laboratory.
  • Liu J; Xi'an Jiaotong University.
  • Li J; Lawrence Berkeley National Laboratory.
  • Ren GG; Lawrence Berkeley National Laboratory.
Res Sq ; 2022 Feb 04.
Article en En | MEDLINE | ID: mdl-35132405
ABSTRACT
Enveloped viruses, including human immunodeficiency virus (HIV) and SARS-CoV-2, target cells through membrane fusion process. The detailed understanding of the process is sought after for vaccine development but remains elusive due to current technique limitations for direct three-dimensional (3D) imaging of an individual virus during its viral entry. Recently, we developed a simple specimen preparation method for real-time imaging of metal dynamic liquid-vaper interface at nanometer resolution by transmission electron microscopy (TEM). Here, we extended this method to study biology sample through snapshot 3D structure of a single HIV (pseudo-typed with the envelope glycoprotein of vesicular stomatitis virus, VSV-G) at its intermediate stage of viral entry to HeLa cells in a liquid-phase environment. By individual-particle electron tomography (IPET), we found the viral surface release excess lipids with unbound viral spike proteins forming ~50-nm nanoparticles instead of merging cell membrane. Moreover, the spherical-shape shell formed by matrix proteins underneath the viral envelope does not disassemble into a cone shape right after fusion. The snapshot 3D imaging of a single virus provides us a direct structure-based understanding of the viral entry mechanism, which can be used to examine other viruses to support the development of vaccines combatting the current ongoing pandemic.

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Res Sq Año: 2022 Tipo del documento: Article